Tea polyphenols

About us
Green tea extract
civilization of tea
Herb extract
Biochemistry products
Chinese herb
Material base
Equipment
E-shopping
corona-fz@263.net
Chinese
BIG5

 

DOSAGE OF THE CHINESE ANTICANCER HERBAL

PART A PART B PART C
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pingying: Xingye Shashen
English: Lady's Bell, Upright Ladybell
Latin: Adenophora stricta Miq

Sources:The root of Adenophora stricta Miq. Family Campanulaceae.

Constituents: Containing glycoside, coumarin xanthotoxin or ammoidin etc.

Actions:
Xanthotoxin has highest inhibitory action against EAC and sarcoma 45 growth, 1:10 000 of xanthotoxin was able to onhibit tumor groeth, the inhititory rate was 50%. Extract of the herb was able to change abnormal electric charges on heppatocarcinoma cell's membrane to normal condition.

Indications: It was used to treat lung, liver, bladder cancers and leukemia, etc.

Composite prescription for lung cancer:
Radix Rehmanniae 12g
Radix Glehniae 12g
Radix Adenophrae 12g
Radix Ophiopogonis 12g
Radix Trichosanthis 12g
Semen Vaccariae 12g
Sargassum 12g
Thallus Laminariae 12g
Radix Saluiae Miltiorrhizae 12g
Squama Manitis Preparata 12g
Carapax Trionycis Preparata 12g
Radix Scrophulariae 15g
Spica Prunellae 15g
Cortex Lycii 30g
Flos Chrysanthemi Indici 30g
Cassiae Occidentalis 30g
Rhizoma Discoreae 30g
Herba Hedyotis Diffusae 30g
Herba Taraxaci 30g
Herba Saluiae Chinensis 30g
Herba Cynanchi Paniculati 30g
Concha Ostreae Calcined 30g
Herba Solani Lyrati 30g
Herba Houttuyniae 30g
Herba Violae 30g
Fructus Schisandrae 6g
Radix Stemonae 9g
Bulbus Fritillariae Cirrhosae 9g
Bulbus Fritillariae Thunbergii 9g
Cortex Moutan 9g

The decoction of the herbs was taken to treat 204 cases of primary lung cancer including 108 squamous cell epithelioma, 43 adenocarcinoma, 27 undifferentiated carcinoma and 26 undifferentiated type. The clincal effect showed that cases of survival time above 1 year were 76 cases, including 47.06% squamous cell epithelioma, 38.24% adenocarcinoma, 30% undifferentiated cancer, cases of survival time above 3 years were 1.92% of squamous cell carcinoma and 4.49% of adenocarcinoma.

  
 

All Copy: FuZhou Corona Science & Technology Development Co.,Ltd.
Head Office Tel:  86-591-8376-9772 ;  8376-9751    Fax:  86-591-8376-9723
Copyright© 2001-2008 All right reserved